Essential Psychopharmacology Volume 3 is organized by Hatherleigh Medical Education
• An Update on New Medications for the Treatment of Major Depressive Disorder
• Treating Insomnia
• Antipsychotic Polypharmacy in Psychosis
• Pharmacological Enhancement of Cognition in Schizophrenia
• Adjunctive Pharmacological Agents in the Treatment of Schizophrenia
|Registration Name||Category||Last Date||Price|
|Digital Only||Course Registration Fee||USD 55.00|
|Digital Plus Print||Course Registration Fee||USD 65.00|
This course awards 10 AMA PRA Category 1 CME credits upon completion.
American Medical Association
The Hatherleigh Company, Ltd. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The Hatherleigh Company, Ltd. designates this CME activity for a maximum number of 10 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
American Psychological Association
The Hatherleigh Company, Ltd. is approved by the American Psychological Association to sponsor continuing education for psychologists. Hatherleigh maintains responsibility for the program and its' content.
MENTAL HEALTH COUNSELORS
National Board for Certified Counselors, Inc.
The Hatherleigh Company, Ltd. is an NBCC-Approved Continuing Education Provider (ACEPTM) and may offer NBCC-approved CE credit hours for programs that meet NBCC requirements. Programs for which NBCC-approved CE credit hours will be awarded are identified on the Website. The ACEP is solely responsible for all aspects of the program. Our NBCC provider number is #5448.
The American Nurses Credential Center’s Commission on Accreditation (ANCC) accepts CE programs by an American Psychological Association approved provider.
Toll free Number
Healthcare Management +12 More
AMA PRA Category 1 Credit™ 10
AMA PRA Category 1 Credit™ 120